TEER shows potential to boost outcomes for cardiogenic shock patients

Transcatheter edge-to-edge repair (TEER) with the MitraClip device can boost short-term outcomes for patients with cardiogenic shock (CS) and significant mitral regurgitation (MR), according to new research published in JACC: Cardiovascular Interventions.

CS with MR has been linked to a heightened risk of morbidity and mortality, the study’s authors explained. To evaluate the effectiveness of TEER with Abbott Vascular’s MitraClip as a treatment option, they tracked data from more than 600 patients who underwent the procedure from 2014 to 2018. All data came from the Nationwide Readmissions Database.

Nearly 60% of patients were male, and the median patient age was 73 years old. An acute myocardial infarction (AMI) had been experienced by 28% of the cohort. The AMI patients were more likely to require mechanical circulatory support (MCS) and have a history of coronary artery disease. They were less likely to have atrial fibrillation.

Importantly, the rate of in-hospital mortality was higher among AMI patients (29.6% vs. 20.4%). These numbers represent a significant improvement compared to results of another recent study that found an in-hospital mortality rate of 55% to 60% among AMI patients with severe MR.

“It is not entirely clear why patients in the non-AMI group had better survival than their counterparts with AMI,” wrote lead author Medhat Farwati, MD, a specialist with Cleveland Clinic, and colleagues. “Although most baseline characteristics of the AMI and non-AMI groups were similar, MCS use was substantially lower in the latter group compared with those with AMI. This probably indicates a more favorable hemodynamic profile in the non-AMI group and thus may result in improved survival.”

The team did note that 30-day readmission rates were comparable between AMI and non-AMI patients.

“Our data suggest that TEER with MitraClip in patients with CS and significant MR, although associated with high mortality and readmission rates, maybe a reasonable therapeutic option in this highly morbid population and may improve short-term outcomes,” Farwati et al. wrote. “However, more data are needed to evaluate relative efficacy of this treatment compared with other options in these very high-risk patients.”

Read the full research letter here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup